This is concerning for mental health risks, since some doctors are prescribing semaglutide medications or other Ozempic alternatives to patients with bipolar disorder to combat the weight gain associated with antidepressants
Bayram H
If you refer a friend, you will receive a referral credit
PMID: 41429154 Diabetes Metab Syndr Obes Opaganib Promotes Weight Loss and Suppresses High-Fat Diet-Induced Obesity and Glucose Intolerance
Armulik A, Genov G, Me M, Nisancioglu MH, Wallgard E, Niaudet C, et al
Adults seeking the strongest available weight-loss outcome in a brand-name SKU Adults with obesity and moderate-to-severe OSA (cross-listed indication) Adults with pre-diabetes and obesity who want T2D progression prevention Clients who plateaued on a semaglutide SKU and want a tirzepatide trial Clients comfortable with weekly subcutaneous injection In SURMOUNT-5, a 72-week head-to-head trial sponsored by Eli Lilly, adults on Zepbound (tirzepatide) achieved 20.2% mean body weight loss, compared with 13.7% for adults on Wegovy (semaglutide)
